ReviewFrontiers in pediatrics2025
Prophylactic heminephrectomy for an asymptomatic, non-functioning moiety in pediatric duplex systems: is cancer prevention justified?
Review in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Duplication of the collecting system (DCS) is common. The management of asymptomatic, non-functioning moieties remains controversial because of a theoretical risk of malignancy, and prophylactic heminephrectomy is occasionally proposed despite the standard practice of reserving surgery for symptomatic complications. Objective: To critically appraise whether current evidence supports prophylactic heminephrectomy solely for cancer prevention in asymptomatic pediatric duplex systems. Methods: We conducted a focused narrative mini-review of PubMed (updated May 2025) and population-based cancer registries, concentrating on absolute malignancy risk and DCS-specific oncologic evidence. Evidence synthesis: Pediatric renal tumors are rare (Wilms tumor ≈7-10 per million children annually; pediatric renal cell carcinoma is even less frequent). The purported association between DCS and malignancy is based on six pediatric case reports (four Wilms tumors and two renal cell carcinomas). No denominator-based cohort data demonstrate an incidence above baseline. Mechanistic plausibility for carcinogenesis in a quiescent, uninfected, non-functioning moiety remains unproven. Although minimally invasive heminephrectomy is generally safe in experienced centers, complications such as bleeding, urinary leak, ureteral stump problems, and potential compromise of the preserved moiety are clinically relevant. Conclusions: Current evidence does not support routine prophylactic heminephrectomy for asymptomatic, non-functioning moieties in children. A conservative strategy with structured ultrasound surveillance at 6-12-month intervals and predefined surgical triggers is prudent and consistent with the available evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.